chr13-113822150-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000820.4(GAS6):c.1690C>A(p.Leu564Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00049 in 1,590,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000820.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GAS6 | NM_000820.4 | c.1690C>A | p.Leu564Ile | missense_variant | 14/15 | ENST00000327773.7 | |
GAS6-AS1 | NR_044995.2 | n.82+6459G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GAS6 | ENST00000327773.7 | c.1690C>A | p.Leu564Ile | missense_variant | 14/15 | 1 | NM_000820.4 | P1 | |
GAS6-AS1 | ENST00000458001.2 | n.62+6459G>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152226Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000359 AC: 79AN: 219806Hom.: 0 AF XY: 0.000371 AC XY: 44AN XY: 118664
GnomAD4 exome AF: 0.000499 AC: 718AN: 1438604Hom.: 0 Cov.: 31 AF XY: 0.000542 AC XY: 386AN XY: 712228
GnomAD4 genome AF: 0.000407 AC: 62AN: 152344Hom.: 0 Cov.: 34 AF XY: 0.000362 AC XY: 27AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.1690C>A (p.L564I) alteration is located in exon 14 (coding exon 14) of the GAS6 gene. This alteration results from a C to A substitution at nucleotide position 1690, causing the leucine (L) at amino acid position 564 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at